Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect of Vildagliptin in Type 2 Diabetes Treated With Sulphonylurea and Metformin
This study is currently recruiting participants.
Verified January 2012 by Seoul National University Bundang Hospital
Study NCT01099137   Information provided by Seoul National University Bundang Hospital

First Received on April 5, 2010.   Last Updated on January 5, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 2
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
Vildagliptin
Sulphonylurea dose-up
Additional drug interventions recognized in this trial
Metformin
More general drug interventions related to this trial
Dipeptidyl-Peptidase IV Inhibitors
Enzyme Inhibitors
Hypoglycemic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protease Inhibitors
Sponsors listed in this trial
Seoul National University Bundang Hospital


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services